drugset / Trial / NCT00182845

Donepezil in the Prevention of Post-Operative Cognitive Decline

NCT00182845

Phase 4 Completed 30 enrolled Pfizer
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate the feasibility of using Donepezil to prevent post-operative cognitive decline (POCD) among individuals aged 65 and older who have a baseline mild cognitive impairment (MCI) and are undergoing elective hip or knee replacement.

Timeline

Start
2005-02
Primary completion
2007-04
Completion
2007-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule

Indications